Abstract

This evidence synthesis is to serve National Immunization Technical Advisory Groups (NITAGs) in their systematic, evidence-based consideration of PCV introduction for routine use among children in national immunization programs.

Evidence is synthesized on the topics that inform vaccine introduction decisions, including: preventable disease burden, vaccine safety and efficacy, vaccine dosing, vaccine impact, economic impact and programmatic considerations.

  • Pneumococcal disease